Safety Summary: AOD-9604 has one of the cleanest safety profiles in the peptide research space
Potential risks Serious risks and adverse events include: Allergic reaction to the medications or dye used in the injection Shoulder infection Depigmentation of the skin around the injection site (a whitening of the skin) Local fat atrophy around the injection site (thinning of the skin) Rupture of a tendon located in the path of the injection Nerve damage near the shoulder joint Bleeding at the injection site In addition to the above, corticosteroid injections increase the risk of: High blood pressure High blood sugar Decreased immune function Decrease in bone mineral density Bone infection (osteonecrosis) Reproductive hormone imbalance Metabolic changes (eg, increased appetite, weight gain, and fluid retention) These risks are typically associated with higher doses of corticosteroids, multiple injections, and for people with underlying medical conditions such as diabetes and heart problems
Nursing Mothers: There have been no studies conducted with somatropin in nursing mothers
Bleibt ungelstes Material zurck, wird das Vial fr 10 bis 15 Minuten bei 2 bis 8 Grad Celsius gelagert und erneut geschwenkt
I really think that the ampoules start to lose their potency , not immediately after the expiry date , but fairly soon
Research supporting BPC-157 used injectable administration